The Korea Health Industry Development Institute (KHIDI) is ramping up support for Korean pharma and biotech firms ahead of the 2025 BIO International Convention (BIO USA) in Boston, where it will lead a joint industry pavilion and host multiple networking events aimed at global expansion.

To be held June 16–19 at the Boston Convention and Exhibition Center, BIO USA is the world’s largest biotechnology conference. KHIDI will return to the event with its “Korea Biohealth Hub” pavilion, co-organized with nine other Korean institutions including the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) and Korea Biomedicine Industry Association.

As part of the showcase, KHIDI will co-host a two-day investor relations event on June 17–18, featuring companies housed at its Boston-based C&D Incubation Office. The lineup includes VS PharmTech, ABION, and Karis Bio, along with several other Korean biotechs presenting pipeline updates and licensing goals.

On June 17, KHIDI will also hold a trilateral clinical trial seminar with U.S.-based Biocom California and MTPConnect of Australia, highlighting trial strengths across Korea, the U.S., and Australia. Korean clinical research organization C&R Research will present case studies and discuss global collaboration models.

Networking continues on June 18 with the Korea Night Reception, now in its third year. According to KHIDI, the reception -- co-hosted with its industry partners -- draws more than 700 attendees annually and has become a key business development event during BIO USA.

To close out the week, KHIDI will co-sponsor Korea Bio Innovation Night on the 19th at the Cambridge Innovation Center (CIC) where its U.S. incubation office is based. The event is part of CIC’s Thursday Venture Café series and will feature startup pitches, panels, and networking with participants from Korea, Canada, and other countries. Korean startups MEPSGEN and Intek Scientific are among the expected presenters.

KHIDI launched its K-Blockbuster Global Expansion Project to help local biotechs scale internationally. According to KHIDI, eight new companies joined the C&D office this year, including CJ CheilJedang, Neurophet, Apollon, PROTEINA and Chong Kun Dang, bringing the total number of residents to 30.